Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Nimacimab

CBeyond

Skye Bioscience · Phase 2 · Active, not recruiting · Enrollment 136

NCT06577090

ArmPopulationDoseWeeksEstimandWeight change
Nimacimab injectionPopulation n/rn/rn/rn/rn/r
Nimacimab placebo injectionPopulation n/rn/rn/rn/rn/r
Semaglutide injection + Nimacimab injection 200 mgPopulation n/r200 mgn/rn/rn/r
Semaglutide injection + Nimacimab placebo injectionPopulation n/rn/rn/rn/rn/r
Open-label 300 mg Nimacimab injection (study extension)Population n/r300 mgn/rn/rn/r